Quarterly Consolidated Statement Of Cash Flows

Immuno-Biological Laboratories Co., Ltd. - Filing #7244299

Concept 2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
209,442,000 JPY
209,861,000 JPY
124,644,000 JPY
124,225,000 JPY
Depreciation
15,427,000 JPY
2,333,000 JPY
Impairment losses
JPY
602,000 JPY
Increase (decrease) in allowance for doubtful accounts
JPY
-6,697,000 JPY
Interest and dividend income
-454,000 JPY
-93,000 JPY
Interest expenses
1,260,000 JPY
1,130,000 JPY
Foreign exchange losses (gains)
2,486,000 JPY
-2,700,000 JPY
Decrease (increase) in trade receivables
-41,227,000 JPY
32,707,000 JPY
Decrease (increase) in inventories
4,158,000 JPY
-3,898,000 JPY
Increase (decrease) in trade payables
-625,000 JPY
-1,352,000 JPY
Other, net
2,159,000 JPY
-8,952,000 JPY
Subtotal
190,290,000 JPY
144,191,000 JPY
Interest and dividends received
2,770,000 JPY
2,818,000 JPY
Interest paid
-3,658,000 JPY
-3,931,000 JPY
Income taxes paid
-5,906,000 JPY
-9,302,000 JPY
Net cash provided by (used in) operating activities
183,495,000 JPY
133,775,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-59,660,000 JPY
-16,160,000 JPY
Other, net
0 JPY
164,000 JPY
Net cash provided by (used in) investing activities
-53,660,000 JPY
-24,496,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
20,000,000 JPY
10,000,000 JPY
Repayments of long-term borrowings
-52,003,000 JPY
-14,008,000 JPY
Other, net
JPY
0 JPY
Net cash provided by (used in) financing activities
-31,755,000 JPY
991,000 JPY
Effect of exchange rate change on cash and cash equivalents
-2,486,000 JPY
2,700,000 JPY
Net increase (decrease) in cash and cash equivalents
95,593,000 JPY
112,971,000 JPY
Cash and cash equivalents
770,563,000 JPY
674,969,000 JPY
561,997,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.